Federation of Neurological Societies guidelines
suggest several additional criteria for AD diagnosis: defining the impact of cognitive decline on activities of daily living, inclusion of information on past medical history, assessing comorbidity (e.g., depression, cardiovascular and pulmonary diseases, infections, sleep disturbances), and electroencephalography measurements [6] . [7] that is based on the discovery that a mutation in APP gene was able to induce AD in familial cases of the disease [8] . This led to a (somewhat premature) conclusion that Aß is the main trigger of the disease in both FAD and sporadic AD, and that it causes all subsequent changes, including tangle formation. The finding that mutations of the MAPT gene cause a pure tauopathy without Aß accumulation [9, 10] further supported this framework of interpretation.
However, neuropathological data actually did not fit well with the amyloid hypothesis [11] . For example, Braak and colleagues have shown that tau pathology in the entorhinal and hippocampal regions precedes Aß accumulation by as much as 27 years [12] and recent data suggest that this delay may even be much longer. Tau-positive materials labeled by the AT8 monoclonal antibody (that shows early neurofibrillary degeneration), were observed in high proportion (38/42) of children and young adults in the absence of Aß accumulation [13] . As AD is traditionally viewed as a disorder associated with aging (more specifically, with old age) early tau pathology seen in children and young adults, if confirmed, could completely alter our view on brain aging [14] . Taking all of these findings into account it is not surprising that over twenty recent clinical trials of potential disease-modifying drugs based on manipulation of Aß (including active immunization) have failed [15] . Moreover, in the recently abandoned semagacestat trial, some patients on the drug got worse -the drug that was designed to inhibit formation of Aß sped up cognitive decline. One plausible explanation is that the formation of Aß might be in fact the brain's protective mechanism against the disease process, whereas the progression of the pathological changes of the neuronal cytoskeleton, rather that Aß burden, is crucial in determining the severity of the dementia syndrome in AD [16] [17] [18] [19] .
Under the assumption that the pathological lesions developing during the course of AD are directly or indirectly attributable to the aging process, a central position in the pathogenesis of AD has been variously assigned to all factors that are known to be capable of damaging postmitotic cells (a risk that increases during aging and old age), such as greater oxidative stress, chronic inflammation, mitochondrial dysfunction and failure of the ubiquitinproteasome system [20] .
One of the underestimated potential causes of all of these changes is reactivation of a latent infection with herpes simplex virus type 1 (HSV1). As inflammatory responses and oxidative changes have been amply documented in AD brains [21, 22] [29] , possibly in relation to very early neurofibrillary AD changes in the dorsal raphe [19] , locus coeruleus and other brainstem nuclei [13] . It is interesting to note that although most of the population is infected with this virus only 25-40% develop cold sores [30] .
Herpes simplex encephalitis is a rare, very serious acute neurological condition.
Interestingly, infection afflicts regions most prominently affected in AD, such as the hippocampus and fronto-temporal cortices [31] . APOE is a 299 amino acid protein involved in the mobilization and redistribution of lipids and cholesterol during neuronal growth and repair. Protein apoE exists in three major isoforms, types e2, e3, and e4, which differ only in residues 112 and 158, placed in the N-terminal, receptor-binding domain. In the early 1990s isoform 4 of the APOE gene was revealed as a susceptibility factor for AD [40] .
APOE4 has been associated with enhanced depolymerization of microtubules [41] , lower density of cholinergic neurons in AD [42] , reduced neuronal remodeling [43] , but also with a worse prognosis after HIV infection [44] and traumatic brain injury [45] .
APOE-e4 plays different roles during infection
by certain pathogens -while associated with a worse prognosis after HIV infection, it also acts protectively during hepatitis C virus-induced liver damage [46] . APOE genotype has been found to determine the outcome of infection by HSV1 -people who develop cold sores after HSV1 infection are more likely to carry APOE-e4 [47] , while there is preliminary evidence on a relatively small number of cases that APOE-e2 might be a risk factor for HSE [48] . Furthermore, the APOE-e4e4 variant has a protective effect in female postherpetic neuralgia, while giving susceptibility to shingles in women. APOEe2e2 causes earlier infection with malaria, while APOE-e2 determines the outcome of pulmonary tuberculosis in women [24] .
After infection, the viral DNA load in mice depends on the presence of APOE gene, and is even higher when the host carries an APOE4 allele (13-fold more HSV1 DNA in brain compared to APOE3 carriers) [49] .
Furthermore, HSV1 is vertically transmitted, and the virus colonizes brains of all offspring of infected mothers [50] . Vertical transmission does not depend on APOE genetic status, but the amount of virus in the brain is dependent on APOE allele type, dosage and gender, with female offspring carrying APOE4/4 genotype having the highest viral loads [51] .
To study the impact of different isoforms of APOE on HSV1 gene expression, transgenic mice that express human isoforms e2, e3, e4
and no APOE were constructed [52] . The HSV1-infection of primary neuronal cortical cultures of these animals revealed higher expression of immediate early genes of the virus in APOE-e4 and knockout strains. Regarding infection of the APOE-e4 strain, a delay in expression of the latency associated transcripts was observed.
Together these data suggest that APOE-e4 allele provides a more conducive environment for HSV replication and spread than the other APOE alleles, perhaps retaining the virus in the lytic phase of its life cycle for a longer period.
Summary of selected research
and hypotheses in support of the connection between HSV1 infection and AD It was noted that a combination of APOE-e4 carriage and latent HSV1 infection confers greater risk of developing AD [47, 53] . The supposed link between APOE and HSV1 could be their competition for binding to heparin sulfate proteoglycans on the cell surface.
The isoform e4 could posses weaker binding properties compared to isoforms e2 and e3.
Another explanation is that e4 is less efficient In situ PCR of HSV1 DNA and thioflavin S staining of amyloid plaques in postmortem brain tissue revealed their colocalization [67] .
While the amount of plaques that associated with HSV1 DNA was similarly high in AD and normal brains, being 90% and 80% respectively, the amount of HSV1 DNA that colocalized with plaques was significantly higher in AD brains, being 74%, compared to 24% in normal temporal and frontal cortices. It is interesting to note that all but one AD case carried at least one APOE e4 allele, and none of the aged controls.
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